Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Topical Tranexamic Acid in High Risk TJA
NCT02644473Phase 4Withdrawn
- Sponsor
- Albert Einstein College of Medicine
- Start
- Feb 2016
- Primary completion
- Jan 2019
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of tranexamic acid, sponsored by Albert Einstein College of Medicine. Planned start Feb 2016; status: withdrawn.
02
Drugs
tranexamic acid
Beyond the preview
Go deeper on NCT02644473.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02644473.